Quantcast

Industry news that matters to you.  Learn more

Children’s Hospital Colorado and SomaLogic Announce Collaboration to Develop Novel Diagnostic Tests

Children’s Hospital Colorado and SomaLogic, Inc., recently announced that they have entered into a collaborative agreement to discover protein biomarkers and use those biomarkers to develop laboratory tests to improve the diagnosis and management of childhood diseases. The discovery and development work will be done using SomaLogic’s novel proteomics SOMAscan™ assay, which can measure more than a thousand proteins in a small amount of blood or other biological samples. This innovative collaboration is being entered into as a result of successful initial exploratory research done by the two organizations.

KineMed and CHDI Foundation Extend Huntington’s Disease Collaboration

KineMed, Inc. and CHDI Foundation, Inc. recently announced an extension of their collaboration that uses KineMed’s translational biomarker platform to characterize and track the pathogenesis of Huntington’s disease (HD) and evaluate potentially therapeutic interventions.

Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating

Two of North America’s leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), recently announced what is likely the largest collaboration of its kind to accelerate discoveries in cancer research.

SAP Announces Strategic Alliances to Drive Forward Genomic Research

SAP AG recently announced a strategic collaboration with Stanford School of Medicine to research the contribution of genetics, environmental exposures, behavior and other factors to disease susceptibility using the power of the SAP HANA platform. The company also announced its participation in the Global Alliance for Genomics and Health, a council of industry leaders working toward accelerating worldwide efforts to responsibly share and analyze large amounts of genomic and clinical data.

KalGene Pharmaceuticals, Sunnybrook Research Institute, Ontario Cancer Biomarker Network and CIMTEC Announce Multi-year Collaboration to Tackle Aggressive Cancers

KalGene Pharmaceuticals, Inc. (KalGene) is expediting development of a prognostic marker and companion therapeutic that specifically targets aggressive cancers.